Credit Suisse’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Credit Suisse’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,000	Closed	-$28K	–	3298
2023 Q1	$28K	Hold	40,000	–	–	﹤0.01%	3248
2022 Q4	$32.8K	Hold	40,000	–	–	﹤0.01%	3439
2022 Q3	$42K	Sell	40,000 -19	-0%	-$30	﹤0.01%	3547
2022 Q2	$66K	Sell	40,019 -2,699	-6%	-$5.61K	﹤0.01%	3600
2022 Q1	$126K	Sell	42,718 -2,196	-5%	-$7.7K	﹤0.01%	3458
2021 Q4	$214K	Buy	+44,914	New	+$290K	﹤0.01%	4250
2020 Q4	–	Sell	-25,015	Closed	-$173K	–	4481
2020 Q3	$173K	Buy	+25,015	New	+$152K	﹤0.01%	3866

Other funds holding SURF

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse's SURF Position: Q2 2023 in Review

Credit Suisse sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 40,000 shares — an estimated $28K sold.

Credit Suisse first reported a position in SURF in Q3 2020 and held it in 7 quarters. The position peaked at $214K in Q4 2021. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

Credit Suisse reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Credit Suisse sold 40,000 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $28K.
Credit Suisse first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Credit Suisse's Surface Oncology, Inc. Common Stock position peaked at $214K in Q4 2021.
61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.